Your session is about to expire
← Back to Search
Imaging Device
Evaluation of C-Scan Capsule in Identifying Subjects With Elevated Risk of Colon Polyps
N/A
Waitlist Available
Research Sponsored by Check-Cap Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4-10 days post colonoscopy
Awards & highlights
No Placebo-Only Group
Summary
This trial tests a new method where people swallow a small capsule that takes pictures inside their body to find colon polyps. It targets people who are at high risk for these polyps. The capsule's pictures are checked for accuracy. Capsule colonoscopy is a minimally invasive imaging method that has been shown to be feasible, accurate, and safe in detecting colonic polyps.
Eligible Conditions
- Healthy Subjects
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4-10 days post colonoscopy
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4-10 days post colonoscopy
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Demonstrate the accuracy of the C-Scan system in identifying subjects with colon polyps comparing to optical colonoscopy (OC).
Secondary study objectives
Demonstrate subjects' satisfaction and usability with the C-Scan System
Colonoscopy
Demonstrate the safety of the C-Scan System
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: C-Scan SystemExperimental Treatment1 Intervention
All study participants will undergo the C-Scan System procedure, followed by a standard of care optical colonoscopy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
C-Scan System
2018
N/A
~290
Find a Location
Who is running the clinical trial?
Check-Cap Ltd.Lead Sponsor
8 Previous Clinical Trials
1,442 Total Patients Enrolled